Piramal Pharma Ltd. (PPLPHARMA) Share Price Rises 2.91% Today
- September 21, 2026
- Posted by: Harsh Piplani
- Category: News
Piramal Pharma Ltd. Share Price is in focus after the stock rose 2.91% to Rs 214.05 from the previous close of Rs 208. The move added Rs 6.05 in a session that opened at Rs 208.65, touched a high of Rs 214.30 and a low of Rs 207.95. The company’s market capitalisation stood at Rs 27,692.04 cr, which places today’s move in a clear market-cap context for Piramal Pharma Ltd. Share Price Today watchers. The supplied data confirms a same-day price rise, but it does not establish a company-specific catalyst. For readers following Piramal Pharma Ltd. Stock News, the most relevant facts are the day’s price action, turnover of Rs 3.29 cr and the valuation and sector comparisons that frame the move.
In Univest coverage, Piramal Pharma Ltd. Share Price Today is best read as an event-led update rather than a cause-led story. The stock’s move has come with no verified trigger in the supplied data, so the article focuses on what changed on the screen, how Piramal Pharma Ltd. stock stands against the healthcare peer set, and what investors can monitor next through Univest.
Piramal Pharma Ltd. Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 214.05 |
| Previous Close | Rs 208 |
| Today's Move | Rs 6.05 (+2.91%) |
| Open | Rs 208.65 |
| High | Rs 214.3 |
| Low | Rs 207.95 |
| Turnover | Rs 3.29 crore |
| Market Capitalisation | Rs 27,692.04 crore |
| Market Cap Category | Large Cap |
Piramal Pharma Ltd. (PPLPHARMA) rose to Rs 214.05 from the previous close of Rs 208, a move of Rs 6.05 or 2.91%. The stock opened at Rs 208.65, reached a high of Rs 214.3, recorded a low of Rs 207.95.
Piramal Pharma Ltd. Share Price Today gained Rs 6.05, or 2.91%, to close at Rs 214.05. The stock traded between Rs 207.95 and Rs 214.30 during the day, compared with the previous close of Rs 208 and the opening price of Rs 208.65. Turnover was Rs 3.29 cr. The supplied data confirms a positive same-day price rise, but it does not establish a company-specific reason for the move.
Piramal Pharma Ltd. (PPLPHARMA) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 27,692.04 crore |
| P/B Ratio | 3.46x |
| ROE | -4.04% |
| ROCE | 1.24% |
| EPS | Rs -2.36 |
| Book Value Per Share | Rs 60.13 |
| Dividend Yield | 0% |
Piramal Pharma Ltd. (PPLPHARMA) fundamental metrics show P/B 3.46x, ROE -4.04%, ROCE 1.24%. These figures provide context only and are not a buy or sell signal.
Piramal Pharma Ltd. has a market capitalisation of Rs 27692.04 crore and falls in the Large Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/B at 3.46x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of -4.04% and ROCE of 1.24%, helping investors compare shareholder returns and capital efficiency. Additional supplied metrics include EPS of Rs -2.36, book value per share of Rs 60.13, dividend yield of 0%, adding context to earnings, balance-sheet value and historical payout. Against the supplied same industry benchmark, these figures can be compared with benchmark median P/E of 32.87x, median ROE of 11.7%, median ROCE of 13.46%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Benchmark Median P/E | 32.87x |
| Benchmark Average P/E | 48.77x |
| Benchmark P/E Range | 3.4x to 683.5x |
| Company P/B Ratio | 3.46x |
| Benchmark Median P/B | 3.08x |
| Company ROE | -4.04% |
| Benchmark Median ROE | 11.7% |
| Company ROCE | 1.24% |
| Benchmark Median ROCE | 13.46% |
| Company Market Capitalisation | Rs 27,692.04 crore |
| Benchmark Median Market Cap | Rs 701.78 crore |
Piramal Pharma Ltd. (PPLPHARMA) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.
Piramal Pharma Ltd. (PPLPHARMA) has a ROE of -4.04%, which is below the benchmark median of 11.7%, a difference of -134.53%. Piramal Pharma Ltd. (PPLPHARMA) has a ROCE of 1.24%, which is below the benchmark median of 13.46%, a difference of -90.79%.
Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | SUNPHARMA | 4,40,397.93 | 36.41 | 5.09 | 14.85 | 19.11 |
| Divi's Laboratories Ltd. | DIVISLAB | 2,48,664.42 | 85.01 | 14.08 | 16.19 | 21.51 |
| Torrent Pharmaceuticals Ltd. | TORNTPHARM | 1,82,738.23 | 83.79 | 20.36 | 26.76 | 19.27 |
| Zydus Lifesciences Ltd. | ZYDUSLIFE | 1,15,012.19 | 25.48 | 4.27 | 19.69 | 21.39 |
| Cipla Ltd. | CIPLA | 1,10,793.75 | 32.87 | 3.15 | 11.83 | 16 |
Its ROE of -4.04% compares with a peer median of 16.19% across the companies shown in the table. ROCE stood at 1.24% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Piramal Pharma Ltd. (PPLPHARMA) has a market capitalisation of Rs 27,692.04 crore. Among the 5 peers shown, 5 have a larger market capitalisation.
Why Investors Are Watching Piramal Pharma Ltd.
- Piramal Pharma Ltd. Share Price rose 2.91% today to Rs 214.05, after closing at Rs 208 in the previous session.
- The day’s range was Rs 207.95 to Rs 214.30, while turnover stood at Rs 3.29 cr.
- Market capitalisation was Rs 27,692.04 cr, which places Piramal Pharma Ltd. Share Price in a large absolute market-cap context.
- P/B was 3.46, compared with the industry median of 3.08 and average of 4.31 in the same industry benchmark.
- EPS was Rs -2.36, ROE was -4.04% and ROCE was 1.24%, which are important context points for Piramal Pharma Ltd. Fundamental Analysis.
About Piramal Pharma Ltd.
Piramal Pharma Ltd. operates in the Pharmaceuticals & Drugs industry within the Healthcare sector. The supplied data does not break down segment revenue, so the company description here stays limited to the verified market classification and the financial profile available for Piramal Pharma Ltd. Share Price readers. Based on the dataset, the key visible context is that the business is part of a large and competitive pharmaceutical universe that includes established Indian listed names such as Sun Pharmaceutical Industries Ltd., Divi’s Laboratories Ltd., Torrent Pharmaceuticals Ltd., Zydus Lifesciences Ltd. and Cipla Ltd. For anyone following Piramal Pharma Ltd. Stock News or Piramal Pharma Ltd. Latest News on Univest, the company’s position is best understood through its market cap, valuation multiples, profitability measures and peer comparisons rather than through any unsupported story line.
Track Piramal Pharma Ltd. Share Price on Univest
Use Piramal Pharma Ltd. (PPLPHARMA) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top-gainers lists and related market analysis.
Readers can track Piramal Pharma Ltd. Share Price Live, Piramal Pharma Ltd. Share Price Update, Piramal Pharma Ltd. Market Cap, Piramal Pharma Ltd. Shareholding Pattern and Piramal Pharma Ltd. Stock Performance on Univest. The platform also helps users review Piramal Pharma Ltd. Fundamental Analysis, sector context, 52-week levels and market insights in one place. For investors monitoring Piramal Pharma Ltd. Share Price Today, Univest keeps the latest data organised for quick comparison with Piramal Pharma Ltd. NSE and Piramal Pharma Ltd. BSE references.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions
Why did Piramal Pharma Ltd. Share Price rise today?
Ans. Piramal Pharma Ltd. Share Price rose 2.91% to Rs 214.05 today, but the supplied data does not establish a company-specific catalyst. The article therefore focuses on verified price action, valuation and sector context.
What is Piramal Pharma Ltd. Share Price today?
Ans. Piramal Pharma Ltd. Share Price today is Rs 214.05. It was up Rs 6.05, or 2.91%, from the previous close of Rs 208, with the day’s range between Rs 207.95 and Rs 214.30.
What is Piramal Pharma Ltd. market capitalisation?
Ans. Piramal Pharma Ltd. market capitalisation stood at Rs 27,692.04 cr. That places the company well above the median and average market cap in the same industry benchmark, based on the supplied sector snapshot.
How does Piramal Pharma Ltd. compare with sector valuation?
Ans. Piramal Pharma Ltd. has a P/B ratio of 3.46, compared with the industry median of 3.08 and average of 4.31. That places the stock above the median but below the average in the same industry set.
What do Piramal Pharma Ltd. EPS and book value show?
Ans. Piramal Pharma Ltd. reports EPS of Rs -2.36 and book value of Rs 60.13. EPS shows earnings attributable to each share, while book value per share reflects the accounting net worth behind each share.
Is Piramal Pharma Ltd. profitable on ROE and ROCE?
Ans. Piramal Pharma Ltd. shows ROE of -4.04% and ROCE of 1.24%. Both figures sit below the industry benchmark in the supplied data, which is important context for Piramal Pharma Ltd. Fundamental Analysis.
Which peers are most relevant for Piramal Pharma Ltd. Share Price?
Ans. The supplied peer set includes Sun Pharmaceutical Industries Ltd., Divi's Laboratories Ltd., Torrent Pharmaceuticals Ltd., Zydus Lifesciences Ltd. and Cipla Ltd. These names help frame Piramal Pharma Ltd. Share Price against comparable healthcare valuations.
